Literature DB >> 6423125

Postmarketing surveillance of adverse reactions to drugs.

M D Rawlins.   

Abstract

Mesh:

Year:  1984        PMID: 6423125      PMCID: PMC1441682          DOI: 10.1136/bmj.288.6421.879

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  6 in total

1.  Post-marketing surveillance of adverse reactions to new medicines.

Authors:  A B Wilson
Journal:  Br Med J       Date:  1977-10-15

2.  Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"?

Authors:  D H Lawson; D A Henry
Journal:  Br Med J       Date:  1977-03-12

3.  Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

4.  The use of vital and morbidity statistics for the detection of adverse drug reactions and for monitoring of drug safety.

Authors:  P D Stolley
Journal:  J Clin Pharmacol       Date:  1982 Nov-Dec       Impact factor: 3.126

5.  Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

6.  Erythromycin estolate and jaundice.

Authors:  W H Inman; N S Rawson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-18
  6 in total
  11 in total

1.  Ethical aspects of the safety of medicines and other social chemicals.

Authors:  Dennis V Parke
Journal:  Sci Eng Ethics       Date:  1995-07       Impact factor: 3.525

Review 2.  Drug toxicity.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

3.  Clinical pharmacology in Europe: an indispensible part of the health service. WHO Working Group on Clinical Pharmacology in Europe.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Adverse reactions in ten years' general practice, computer analysed.

Authors:  R A Johnson
Journal:  J R Soc Med       Date:  1986-03       Impact factor: 5.344

5.  The role of record linkage in post-marketing drug surveillance.

Authors:  I K Crombie
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

6.  Post-marketing surveillance in the UK (1984).

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 7.  New drugs. Adverse reactions. I.

Authors:  D N Bateman; S Chaplin
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

Review 8.  Marketing aspects of company-sponsored postmarketing surveillance studies.

Authors:  M D Stephens
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

9.  Pharmacoepidemiology: a new discipline.

Authors:  D H Lawson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-13

Review 10.  Post-approval drug safety surveillance.

Authors:  Robert D Gibbons; Anup K Amatya; C Hendricks Brown; Kwan Hur; Sue M Marcus; Dulal K Bhaumik; J John Mann
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.